MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 290 filers reported holding MIRATI THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,791,539 | +1396.7% | 775,747 | +1177.5% | 0.07% | +1050.0% |
| Q1 2023 | $2,257,718 | +9.4% | 60,724 | +33.3% | 0.01% | 0.0% |
| Q4 2022 | $2,063,463 | -87.9% | 45,541 | -41.2% | 0.01% | -93.7% |
| Q4 2020 | $17,014,000 | +2740.4% | 77,464 | +1567.7% | 0.10% | +2275.0% |
| Q4 2019 | $599,000 | -81.2% | 4,645 | -93.8% | 0.00% | -82.6% |
| Q4 2018 | $3,189,000 | -33.5% | 75,166 | -18.9% | 0.02% | +4.5% |
| Q3 2018 | $4,796,000 | +2041.1% | 92,732 | +653.9% | 0.02% | +2100.0% |
| Q4 2017 | $224,000 | -11.5% | 12,300 | -43.1% | 0.00% | 0.0% |
| Q3 2017 | $253,000 | 0.0% | 21,600 | +169.3% | 0.00% | -50.0% |
| Q4 2015 | $253,000 | -83.5% | 8,020 | -84.7% | 0.00% | -83.3% |
| Q1 2015 | $1,535,000 | – | 52,342 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |